Néovacs raises 0.2 million euros through Oceane-BSA issuance


(AOF) – Néovacs announces a fundraising of 0.2 million euros through the issue of Océane-BSA, with a nominal value of 200,000 euros, subscribed by European High Growth Opportunities Securitization Fund. according to the biotech, the net proceeds from this operation, i.e. 192,000 euros, will be intended to finance the Kinoid research program on allergies and to strengthen its investment capacities both in the development of drug candidates and medical devices. The issue of Oceane-BSA gives rise to the issue of 529,100 BSAs.

These BSAs will be transferred back to the company Néovacs with a view to their cancellation, and the issue could give rise to the creation of 1,291,990 new shares based on the last listed price. The participation of a shareholder holding 1% of the capital prior to this new drawing would be 0.71%.

© 2024 Agence Option Finance (AOF) – All reproduction rights reserved by AOF. AOF collects its data from the sources it considers the safest. However, the reader remains solely responsible for their interpretation and use of the information made available to them. The reader must therefore hold AOF and its contributors harmless from any claim resulting from this use. Agence Option Finance (AOF) is a brand of the Option Finance group

Did you like this article ? Share it with your friends using the buttons below.





Facebook


Linkedin


E-mail





Source link -85